Are the So-Called “Killer Acquisitions” Getting a Bad Rap?

Latham & Watkins, San Francisco
12 September 2019
Hosted By: NERA Economic Consulting, Latham & Watkins, Morgan, Lewis & Bockius, and Schiff Hardin

NERA Senior Consultant Dr. Kate Foreman will be joined by Latham & Watkins Associate Kelly Smith Fayne, Morgan Lewis Associate Minna Lo Naranjo, and Shiff Hardin Partner Suzanne L. Wahl for an interesting and thought-provoking panel discussion on the topic of “Killer Acquisitions.”

As four leaders in the field of antitrust law, the panel will discuss several questions, including:

  • What exactly is a killer acquisition?
  • How are regulators tackling killer acquisitions?
  • What do the economics tell us about killer acquisitions?
  • What should business be thinking about going forward?

Date and Timing

Thursday, 12 September 2019
Registration from 11:45 am
Panel from noon to 1:00 pm
Followed by networking opportunities

Venue

Latham & Watkins
505 Montgomery Street, Suite 2000
San Francisco, CA

If you’d like to register to attend this event, please click here.
Please note, this activity is pending approval for 1.0 hours of MCLE credit by the State Bar of California

About the Speakers

Kelly Smith Fayne is an Associate in the Antitrust Practice of Latham & Watkins’ San Francisco office. Ms. Fayne advises clients on government reviews of merger and acquisitions, antitrust compliance and counseling, and government conduct investigations. She also works closely with experts in preparing and presenting antitrust economic analysis and econometrics and has represented clients from a wide range of industries. Ms. Fayne writes frequently on a range of antitrust issues, and currently serves as a senior editor of the American Bar Association’s Antitrust Law Journal.

Dr. Kate Foreman is a Senior Consultant in NERA’s San Francisco office. Her work is focused in antitrust, intellectual property, and life sciences economics. Within the field of antitrust economics, Dr. Foreman has consulted on a number of lawsuits, assessing potential liability and damages in cases involving alleged price fixing, exclusionary contracts, and other anticompetitive behavior. She also has experience evaluating market definition, bidding, and pricing pressure as part of proposed mergers and acquisitions. In the area of intellectual property, she analyzes the value of patents and licenses arising from alleged patent infringement. Her life sciences experience includes the analysis of commercial success in pharmaceuticals, medical device mergers, and patent infringement damages calculations with the first biosimilar.

Minna Lo Naranjo is an Associate based in the San Francisco office of Morgan Lewis. Ms. Naranjo represents clients across the pharmaceutical, technology, airline, oil and gas, and ride-sharing industries. She focuses on civil antitrust cases involving cartel, monopolization, and unfair competition allegations. Her experience includes multidistrict antitrust litigation and class action defense, in which she collaborates with experts on class and damages issues. 

Suzanne L. Wahl is a Partner in Schiff Hardin’s Litigation and Dispute Resolution group. Her practice is focused on antitrust and trade regulation, including representing trade associations in national class action litigation and acting as in-house competition counsel to a Fortune 100 company. She is a 2007 cum laude graduate of the University of Michigan Law School. Ms. Wahl currently serves as a Vice Chair on the ABA Section of Antitrust Law Antitrust-Consumer Protection Law Daily Digest Committee.

To contact us about this event, please click here.